文献速递认知障碍与痴呆

听力干预对轻度认知障碍老年人的影响:CHOICE随机临床试验

Hearing Intervention for Older Adults With Mild Cognitive Impairment: The CHOICE Randomized Clinical Trial.
PubMed 文献 · JAMA Neurol · 2026-09-28

本研究为多中心、平行组、开放标签随机临床试验,纳入703例同时存在轻度认知障碍(MCI)和中重度听力损失的60岁及以上老年人,随机分为助听器干预组(n=353)和听力保健教育对照组(n=350)。预设次要分析显示听力干预提高了认知改善率(CDR=0),干预组15.34% vs 对照组2.36%(RD 12.00%,95%CI 8.79%-15.21%)。

要点

  • 助听器干预未显著降低MCI老年人24个月痴呆水平损害转化率。
  • 听力干预显著提高认知改善率(CDR=0),干预组15.34% vs 对照组2.36%。
  • 研究未报告与研究相关的不良事件。

核心结论

  • 在同时存在MCI和中重度听力损失的老年人中,助听器干预未显著降低24个月痴呆水平损害的发生率。

研究设计与样本

  • 多中心、平行组、开放标签随机临床试验,2021年9月至2024年2月在上海3家三级耳科门诊和3个CHOICE队列社区卫生站开展。
  • 主要结局为24个月内从MCI转化为痴呆水平损害(CDR全局评分≥1)的转化率。

主要发现

  • 预设次要分析:听力干预提高认知改善率(CDR=0),干预组15.34%(95%CI 11.84%-19.62%)vs 对照组2.36%(95%CI 0.99%-5.22%),风险差12.00%(95%CI 8.79%-15.21%),相对风险5.94(95%CI 2.46-14.37)。
  • 未报告与研究相关的不良事件。

关键数值与推荐

  • MCI定义:CDR全局评分为0.5;痴呆水平损害定义:CDR全局评分≥1。
  • 听力损失程度:中重度听力损失。

临床怎么用

  • 对于同时存在MCI和中重度听力损失的老年人,助听器干预虽未显著降低痴呆水平损害转化率,但可提高认知改善率,临床可考虑作为认知健康综合管理的一部分。

局限性

  • 开放标签设计可能引入偏倚。
  • 24个月随访时间可能不足以观察到痴呆转化的显著差异。
  • 完成试验的参与者为610例(86.77%),存在失访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Hearing loss is a significant modifiable risk factor for cognitive decline, but the effectiveness of hearing intervention for cognition stabilization or improvement still remains controversial. OBJECTIVE: To investigate whether hearing intervention could reduce dementia-level impairment incidence in older adults with coexisting hearing loss and mild cognitive impairment (MCI). DESIGN, SETTING, AND PARTICIPANTS: This multicenter, parallel-group, open-label randomized clinical trial was conducted between September 2021 and February 2024, with the 24-month follow-up completed in February 2026. This study was conducted at 3 tertiary otology outpatient clinics and 3 CHOICE cohort community health stations in Shanghai, China. Of 21 908 adults aged 60 years or older assessed for eligibility, 703 participants with coexisting MCI (Clinical Dementia Rating [CDR] global score of 0.5) and moderate to severe hearing loss were enrolled and randomized. These data were analyzed from February 2026 to July 2026. INTERVENTIONS: Participants were randomized 1:1 to receive either hearing aid intervention (n = 353) or hearing care education (n = 350). MAIN OUTCOMES AND MEASURES: The primary outcome was the conversion rate from MCI to dementia-level impairment over 24 months, defined as a CDR global score 1 or more. Key prespecified secondary outcomes comprised rate of cognitive improvement (CDR = 0) and CDR global and domain scores. RESULTS: Among 703 randomized patients (mean [SD] age, 74.53 [7.16] years; range, 60-96 years; 250 female [35.56%] and 452 male [64.44%]), 610 (86.77%) completed the trial. No significant difference was observed in the primary outcome, in which the conversion rate from MCI to dementia-level impairment was 3.09% (95% CI, 1.62%-5.74%) in the intervention group vs 4.74% (95% CI, 2.60%-8.29%) in the control group (risk difference [RD], -2.07%; 95% CI, -4.74% to 0.61%; relative risk [RR], 0.59; 95% CI, 0.25-1.38; P = .23). Meanwhile, prespecified secondary analysis demonstrated that hearing intervention increased the rate of cognitive improvement (15.34%; 95% CI, 11.84%-19.62% vs 2.36%; 95% CI, 0.99%-5.22%; RD, 12.00%; 95% CI, 8.79%-15.21%; RR, 5.94; 95% CI, 2.46-14.37). No study-related adverse events were reported. CONCLUSIONS AND RELEVANCE: In this study, among older adults with mild cognitive impairment and coexisting hearing loss, a hearing aid intervention did not significantly reduce the incidence of dementia-level impairment at 24 months. TRIAL REGISTRATION: Chinese Clinical Trial Registry Identifier: ChiCTR2000036139.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Chen Y, Shi H, Xiang M, et al. Hearing Intervention for Older Adults With Mild Cognitive Impairment: The CHOICE Randomized Clinical Trial. JAMA Neurol. 2026. PMID: 42804222. doi:10.1001/jamaneurol.2026.3395

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。